»ðÀÔÇü Á¦¼¼µ¿±â ȯÀÚ¿¡¼ Kyphoplasty ÈÄ ¹ß»ýÇÑ ½É³»¸·¿°
Infective endocarditis after kyphoplasty in a patient with an implantable cardioverter-defibrillator
International Journal of Arrhythmia 2012³â 13±Ç 1È£ p.37 ~ p.40
Ȳ±³½Â(Hwnag Gyo-Seung) - ¾ÆÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Abstract
Multiple clinical trials have established that the use of an implantable cardioverter-defibrillator (ICD) results in improved survival compared with antiarrhythmic agents for the prevention of sudden cardiac death. The decision for ICD implantation requires not only evidence of clinical benefit demonstrated in randomized clinical trials but also estimates of life expectancy, consideration of comorbidities and procedural risks, and patient preferences. A 74-year-old man with severe left ventricular dysfunction and ventricular tachycardia received an ICD for secondary prevention of SCD. The patient also had diabetes mellitus and chronic renal insufficiency. After kyphoplasty in the thoracic spine, a paravertebral abscess and septicemia occurred and led to fatal infective endocarditis. The benefits of device therapy should be considered in comparison with serious adverse effects, especially in older patients with comorbidities.
Å°¿öµå
endocarditis, implantable cardioverter-defibrillator
KMID :
1011920120130010037
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
After kyphoplasty in the thoracic spine, a paravertebral abscess and septicemia occurred and led to fatal infective endocarditis. The benefits of device therapy should be considered in comparison with serious adverse effects, especially in older patients with comorbidities.